Pemetrexed 500mg/m2 day1 + Carboplatin AUC6 day1, q3w, 3-6 cycles

2 trials

Sponsors

Central Japan Lung Study Group

Conditions

Advanced non-squamous non-small cell lung cancer with EGFR MutationAdvanced non-squamous non-small cell lung cancer without EGFR Mutation

Phase 2

Phase 2 study of Pemetrexed + Carboplatin as first line therapy for non-squamous non-small cell lung cancer without EGFR Mutation (CJLSG0906)

Active, not recruitingJPRN-UMIN000003393

Central Japan Lung Study GroupAdvanced non-squamous non-small cell lung cancer without EGFR Mutation

Start: 2010-02-01Target: 53Updated: 2026-06-29

Phase 2 study of Pemetrexed + Carboplatin as first line therapy for non-squamous non-small cell lung cancer with EGFR Mutation (CJLSG0907)

Active, not recruitingJPRN-UMIN000003394

Central Japan Lung Study GroupAdvanced non-squamous non-small cell lung cancer with EGFR Mutation

Start: 2010-02-01Target: 23Updated: 2026-06-29